o Sleep quality: Both gabapentin and levodopa-c improved sleep quality compared with baseline (P<0.05). When comparing gabapentin and levodopa-c, gabapentin was significantly superior to levodopa for sleep quality (P< 0.0001). Author's conclusion: The study shows that gabapentin (200 mg daily) is a safe and effective treatment over levodopa-c (110mg) for RLS in hemodialysis patients in the short term. Thus, this medication may be considered as an alternative or additive treatment to current therapeutic remedies for this conundrum. o Further research is needed in this field. The study was found to be small and did not use objective tests to identify the efficacy for treatment between regimens. The study did not explain how the patients and research team were masked, if unblinding occurred, and the type of formulations the patients were given or if the patients were compliant with their regimen. Therefore, one can not justify that gabapentin is superior to levodopa-c in the treatment of RLS symptoms in hemodialysis patients.
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